Elobixibat 10 mg
Sponsors
Ferring Pharmaceuticals
Conditions
Chronic Idiopathic Constipation
Phase 3
26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation
TerminatedNCT01827592
Start: 2013-04-30End: 2014-05-31Updated: 2015-10-20
Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic Constipation
CompletedNCT01895543
Start: 2013-09-30End: 2015-05-31Updated: 2016-05-09